Invention Grant
- Patent Title: Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors
-
Application No.: US16526056Application Date: 2019-07-30
-
Publication No.: US10751411B2Publication Date: 2020-08-25
- Inventor: William Jacobs, Jr. , Pablo A. Gonzalez Munoz , Betsy Herold , Christopher Petro
- Applicant: ALBERT EINSTEIN COLLEGE OF MEDICINE
- Applicant Address: US NY Bronx
- Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
- Current Assignee: ALBERT EINSTEIN COLLEGE OF MEDICINE, INC.
- Current Assignee Address: US NY Bronx
- Agency: Cantor Colburn LLP
- Main IPC: A61K39/245
- IPC: A61K39/245 ; A61K39/12 ; C12N7/00 ; C07K14/005 ; A61K39/00
Abstract:
Recombinant herpes simplex virus 2 (HSV-2) vaccine vectors, virions thereof, compositions and vaccines comprising such, and methods of use thereof are each provided.
Public/Granted literature
- US20200023058A1 RECOMBINANT HERPES SIMPLEX VIRUS 2 (HSV-2) VACCINE VECTORS Public/Granted day:2020-01-23
Information query
